PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-23

Date Title Company
23-Sep-2025 Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma Businesswire
23-Sep-2025 Virtuoso Surgical Robotic System Receives FDA Breakthrough Device Designation Businesswire
23-Sep-2025 Lifeloc to Present at Emerging Growth Conference on September 25, 2025 ACCESS Newswire
23-Sep-2025 Drug Farm Announces Agreement with Cincinnati Children’s Hospital Medical Center to Explore ALPK1 Inhibitor, DF-003 as a Potential Treatment for Heart Disease and Blood Cancers Driven by Clonal Hematopoiesis Businesswire
23-Sep-2025 SynGenSys Introduces NK.SET Synthetic Promoter Library to Advance Natural Killer Cell Therapies Businesswire
23-Sep-2025 Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland Mainz BioMed N.V.
23-Sep-2025 The Assistance Fund Marks 100th Disease Program, Expands Support to People Living With Macular Degeneration ACCESS Newswire
23-Sep-2025 Sanofi launches Real Skinformation, an AI-powered website supporting healthcare professionals in tackling online skincare trends and misinformation Sanofi
23-Sep-2025 eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading Cell and Gene Therapy services in Southeast Asia eXmoor Pharma
23-Sep-2025 Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion Sanofi, Regeneron
23-Sep-2025 Abu Dhabi Biobank expands access to cord blood banking services with major NMC Healthcare partnership Abu Dhabi Biobank
23-Sep-2025 C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programme C4X Discovery
23-Sep-2025 EMV Capital acquires antibiotic assets from Destiny Pharma EMV Capital, Destiny Pharma
23-Sep-2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK Myricx Bio
23-Sep-2025 BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer BetaGlue Therapeutics
23-Sep-2025 Servier receives approval from European Commission for Voranigo® (vorasidenib), first targeted therapy for Patients with Grade 2 IDH-mutant Glioma Servier
23-Sep-2025 Canon Introduces Aplio beyond: A Premium Ultrasound Solution Aimed at Expert Users in Demanding, High-Throughput Clinical Environments Canon Medical Systems UK
23-Sep-2025 Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at a list price equal to the US list price Bristol Myers Squibb
23-Sep-2025 New ublituximab data in multiple sclerosis to be presented at ECTRIMS Congress 2025 alongside partner TG Therapeutics Neuraxpharm Group
23-Sep-2025 Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research Biognosys